The Asia Pacific nuclear imaging systems market size is expected to reach US$ 971.42 million by 2031 from US$ 678.45 million in 2024. The market is estimated to record a CAGR of 5.4% from 2025 to 2031.
Executive Summary and Asia Pacific Nuclear Imaging Systems Market Analysis:
The nuclear imaging market in Asia Pacific is the fastest growing market. Major countries in this region are investing in their healthcare infrastructure so as to provide top notch medical care. Hybrid systems such as PET/CT and SPECT/CT are gaining ground because they provide clearer results than traditional scanners. Both public and private providers are expanding their capacity as demand for non-invasive tests grows. China leads the way with its infrastructure, radiopharmaceutical output, and strong clinical adoption. Japan, South Korea, and India are also major markets in Asia Pacific region owing to high cancer prevalence, and government support. The region’s mix of highly advanced and developing healthcare systems creates both challenges and opportunities, especially when it comes to balancing cost with innovation. With imaging spreading into outpatient and specialty care, Asia Pacific is increasingly seen as a hub for research, manufacturing, and clinical use of nuclear imaging.
Asia Pacific Nuclear Imaging Systems Market Strategic Insights
Key segments that contributed to the derivation of the nuclear imaging systems market analysis are product type, application, and end user.
- By product type, the nuclear imaging systems market is segmented into SPECT systems, PET systems and hybrid systems. The PET systems segment dominated the market in 2024.
- By application, the nuclear imaging systems market is segmented into oncology, cardiology, neurology, endocrinology and others. The oncology segment dominated the market in 2024.
- By end user, the market is segmented into hospitals, specialty clinics, diagnostics imaging centers, academic & research Institutes and others. The hospitals segment held the largest share of the market in 2024.
Asia Pacific Nuclear Imaging Systems Market Outlook
Asia Pacific’s nuclear imaging market is being reshaped by the drive for more precise diagnostics and broader healthcare modernization. Demand for hybrid technologies such as PET/CT and SPECT/CT is rising, since they give doctors both anatomical and functional insights in a single scan. This is proving especially valuable in oncology and cardiology, where early detection and careful treatment planning are essential. One important shift is the rise of local radiopharmaceutical production, led by China and India, which is reducing dependence on imports and stabilizing supply chains. This change is also allowing services to move beyond major metropolitan areas into secondary cities, and in some instances, rural areas. The development of private diagnostic networks and outpatient centers is helping create an appetite for smaller, high-performance systems. Government investment in digital health and infrastructure improvements is pushing nuclear imaging into becoming a significant asset in both public and private care.
Asia Pacific Nuclear Imaging Systems Market Country Insights
Based on country, the Asia Pacific nuclear imaging systems Market is further segmented into China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh, and the Rest of Asia. China held the largest share in 2024.
China leads the Asia Pacific nuclear imaging market, owing to the broad healthcare reforms and its industrial strength. The Healthy China 2030 plan has pushed hospitals to adopt advanced systems, from full-body PET scanners to AI-assisted platforms. Domestic isotope production, such as Technetium-99m and Fluorine-18, has increased significantly, which cuts import needs and steadies supply in many provinces. Leading hospitals in Beijing and Shanghai are collaborating with research institutions to advance molecular imaging technologies, with a primary focus on cancer and neurological disorders. Regulatory reforms have streamlined approval processes, offering both domestic and international suppliers a more transparent route into the market. While training programs continue to trail behind growing demand and cost barriers persist, the expansion of imaging centers remains steady. Backed by scale, supportive policies, and a robust manufacturing ecosystem, China is steadily establishing itself as the regional cornerstone for nuclear imaging.
Asia Pacific Nuclear Imaging Systems Market Report Highlights
| Report Attribute | Details |
| Market size in 2024 | US$ 678.45 Million |
| Market Size by 2031 | US$ 971.42 Million |
| CAGR (2025 - 2031) | 5.4% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Product Type
|
|
Regions and Countries Covered
|
|
| Asia Pacific | China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh |
| Market leaders and key company profiles |
|
Asia Pacific Nuclear Imaging Systems Market Company Profiles
GE HealthCare, Siemens Healthineers AG, Canon Inc., Koninklijke Philips N.V., SHIMADZU CORPORATION, United Imaging Healthcare Co., Ltd., Neusoft Medical Systems Co., Ltd., Mediso Ltd., Positron Corporation, and MiE GmbH are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
Asia Pacific Nuclear Imaging Systems Market Research Methodology:
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
- Company websites, annual reports, financial statements, broker analyses, and investor presentations
- Industry trade journals and other relevant publications
- Government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
Primary Research
Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
- Refine findings from secondary research
- Enhance the expertise and market understanding of the analysis team
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
- Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
- External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Asia Pacific Nuclear Imaging Systems Market Country and Regional Insights
Asia Pacific Nuclear Imaging Systems Key Sources Referred:
- The World Bank
- World Health Organization (WHO)
- Center for Disease Control and Prevention (CDC)
- Society of Nuclear Medicine and Molecular Imaging (SNMMI)
- European Association of Nuclear Medicine (EANM)
- American College of Nuclear Medicine (ACNM)
- American Society of Nuclear Cardiology (ASNC)
- Global Cancer Observatory
- Company website
- Company annual reports
- Company investor presentations
